Advertisement

Topics

Affibody Company Profile

11:05 EDT 22nd June 2018 | BioPortfolio

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has obtained outstanding clinical molecular imaging results and promising targeted therapeutics pre-clinical results. Affibody expects to launch one molecular imaging agent per year from 2007 and to file one targeted therapeutics IND every second year.

Location

Voltavägen 13,floor 5
Bromma
SE-168 69
Sweden

Contact

Phone: 46 (0) 8 598 838 00
Fax: 46 (0) 8 598 838 01
Email: reception@affibody.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Beyond antibodies. Are Affibody poised to make the next significant biologics breakthrough?

Affibody is a Swedish biotech company focused on developing next generation biopharmaceuticals based on its unique proprietary technology platforms: Affibody® molecules and Albumod™. During NLSD in...

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Radionuclide therapy of HER2-expressing human xenografts using an affibody molecule-based PNA-mediated pretargeting: in vivo proof-of-principle.

Affibody molecules are small proteins engineered using a non-antibody scaffold. Radiolabeled affibody molecules are excellent imaging probes, but their application for radionuclide therapy was so far ...

Synthesis, Characterization and Biomedical Applications of a Targeted Dual-Modal Near Infrared-II Fluorescence and Photoacoustic Imaging Nanoprobe.

Our development of multifunctional dual-modal imaging probes aims to integrate the benefits from both NIR-II fluorescence (1000 - 1700 nm) and photoacoustic imaging with an ultimate goal of improving ...

Engineering Tunable Dual Functional Protein Cage Nanoparticles Using Bacterial Superglue.

The selective detection of specific cells of interest and their effective visualization is important but challenging, and fluorescent cell imaging with target-specific probes is commonly used to visua...

3D Imaging Detection of HER2 Based in the Use of Novel Affibody-Quantum Dots Probes and Ratiometric Analysis.

Patients with breast cancer (BC) overexpressing HER2 (HER2+) are selected for Trastuzumab treatment, which blocks HER2 and improves cancer prognosis. However, HER2+ diagnosis, by the gold standard, im...

Synergistic Enhancement of Enzyme Performance and Resilience via Orthogonal Peptide-Protein Chemistry Enabled Multilayer Construction.

Protein immobilization is critical to utilize their unique functions in diverse applications. Herein, we report that orthogonal peptide-protein chemistry enabled multilayer construction can facilitate...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

In Vivo IGF-1R Molecular Imaging Using [68Ga]- Labelling Anti-IGF-1R Affibody Molecule

The investigators developed [68Ga]-labelling Anti-IGF-1R Affibody Molecule as a targeted molecular imaging agent for noninvasive and repeatable detecting IGF-1R expression status.

In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule

The investigators developed [68Ga]-labelling Anti-EGFR Affibody Molecule as a targeted molecular imaging agent for noninvasive and repeatable detecting EGFR-ECD expression status.

99mTc Labelled Affibody SPECT/CT Imaging for Breast Cancer HER2 Characterization

This is an open-label single photon emission tomography/computed tomography (SPECT/CT) study to investigate the diagnostic performance and evaluation efficacy of 99mTc-ABH2 in breast cance...

Companies [1 Associated Companies listed on BioPortfolio]

Affibody

Affibody has developed a unique pipeline of affinity ligands in oncology, covering the entire value chain from research reagents to molecular imaging agents and targeted therapeutics. The company has ...

More Information about "Affibody" on BioPortfolio

We have published hundreds of Affibody news stories on BioPortfolio along with dozens of Affibody Clinical Trials and PubMed Articles about Affibody for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Affibody Companies in our database. You can also find out about relevant Affibody Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record